arrow
S

Simon Bond

university college london
H指数:38
被引数:5,200

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial

急性冠状动脉综合征的低剂量IL-2抗炎治疗: 一项随机2期试验

2026-01-080
OAAI
Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial

甲氨蝶呤治疗早期帕金森病(AZA-PD):一项随机、双盲、安慰剂对照、概念验证性、二期临床试验

2025-12-100
OAAI
A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trial

一项务实、随机化、开放标签、多中心、由英国登记系统支持的试验,旨在评估高剂量胆骨化醇对透析患者死亡率的影响:SIMPLIFIED试验

2025-10-150
OAAI
Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional step-up care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial

从诊断开始使用抗肿瘤坏死因子治疗,比常规逐步升级治疗对活动性克罗恩病患者的效果更好且成本更低:PROFILE试验的成本效益分析

2025-09-010
OAAI
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials

Janus kinase抑制剂在因COVID-19住院的成人中的效果:一项随机临床试验的系统评价和个体参与者数据荟萃分析

2025-05-130
OA
Low-Dose IL-2 Lowers Arterial Inflammation and Trends Towards Lower MACE in patients with ACS: The results of the IVORY trial and IVORY FINALE study

低剂量IL-2降低动脉炎症并呈现降低ACS患者主要不良心血管事件(MACE)的趋势:IVORY试验和IVORY FINALE研究的成果

2024-11-120
PRE
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
2024-05-0143
OAAI
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)
2024-03-011
OA
Visualising harms in publications of randomised controlled trials: consensus and recommendations
2022-05-169
OAAI
Trial of Dexamethasone for Chronic Subdural Hematoma
2020-12-31155
OAAI